REGENTIS BIOMATERIALS LTD. - RGNT

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2026 · Compare: Q2 2026
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Rosalind Advisors, Inc. History No change 701,685 1,270 0.41% 0.92% 1 0 0.0% Q3 2026 Nov 16, 2026
Warberg Asset Management LLC History Reduced 58,526 108 0.01% 0.06% 2 -28,454 -32.71% Q3 2026 Nov 02, 2026
CITADEL ADVISORS LLC History New 58,924 106 0.0% — 3 +58,924 New Q3 2026 Nov 16, 2026
JANE STREET GROUP, LLC History Reduced 43,240 78 0.0% 0.0% 4 -93 -0.21% Q3 2026 Nov 12, 2026
Marex Group Ltd History New 29,371 53 0.0% — 5 +29,371 New Q3 2026 Nov 16, 2026
UBS Group AG History Added to 1,246 2 0.0% 0.0% 6 +812 187.1% Q3 2026 Nov 10, 2026
RENAISSANCE TECHNOLOGIES LLC History Closed out 0 0 — 0.0% — -13,348 -100.0% Q3 2026 Nov 12, 2026
Tower Research Capital LLC (TRC) History Closed out 0 0 — — — -11 -100.0% Q3 2026 Nov 16, 2026